US Stock MarketDetailed Quotes

Utah Medical Products (UTMD)

Watchlist
  • 65.900
  • +1.040+1.60%
Close Apr 10 16:00 ET
  • 65.900
  • 0.0000.00%
Post 16:10 ET
209.89MMarket Cap18.94P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Utah Medical Products (UTMD) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-0.94%14.69M
18.39%3.48M
0.57%3.88M
4.02%2.87M
-15.39%4.46M
-33.44%14.83M
-44.92%2.94M
-24.70%3.86M
-43.78%2.76M
-23.70%5.28M
Net income from continuing operations
-18.65%11.29M
-11.58%2.57M
-26.16%2.63M
-11.73%3.05M
-23.13%3.04M
-16.60%13.87M
-32.29%2.9M
-9.45%3.56M
-17.79%3.45M
-6.12%3.96M
Depreciation and amortization
5.69%3.01M
4.11%760K
3.92%769K
9.38%758K
5.56%721K
-55.31%2.85M
-29.81%730K
-58.54%740K
-61.05%693K
-61.28%683K
Deferred tax
-94.97%-659K
-130.51%-18K
-430.19%-281K
6.21%-151K
-14.21%-209K
50.37%-338K
114.43%59K
63.19%-53K
-26.77%-161K
-18,200.00%-183K
Change In working capital
117.58%317K
110.39%86K
158.84%263K
31.87%-870K
11.88%838K
-673.82%-1.8M
-340.00%-828K
11.13%-447K
-32.74%-1.28M
-15.56%749K
-Change in receivables
142.64%333K
190.53%430K
-5,522.22%-506K
578.31%397K
105.61%12K
-134.41%-781K
-446.72%-475K
-110.11%-9K
-132.55%-83K
-111.96%-214K
-Change in inventory
103.58%1.2M
135.44%186K
50.75%101K
272.35%633K
1.48%275K
187.61%587K
-69.02%79K
-79.06%67K
205.59%170K
125.00%271K
-Change in prepaid assets
-68.75%-54K
-23.26%-106K
-1,133.33%-93K
29.55%171K
70.11%-26K
-171.11%-32K
-430.77%-86K
-43.75%9K
700.00%132K
-448.00%-87K
-Change in payables and accrued expense
26.63%-1.16M
-22.54%-424K
248.05%761K
-38.44%-2.07M
-25.93%577K
16.03%-1.58M
-373.97%-346K
44.61%-514K
-44.68%-1.5M
396.18%779K
Cash from discontinued investing activities
Operating cash flow
-0.94%14.69M
18.39%3.48M
0.57%3.88M
4.02%2.87M
-15.39%4.46M
-33.44%14.83M
-44.92%2.94M
-24.70%3.86M
-43.78%2.76M
-23.70%5.28M
Investing cash flow
Cash flow from continuing investing activities
-78.37%-371K
-1,111.11%-109K
69.66%-27K
55.65%-51K
-3,780.00%-184K
67.45%-208K
90.00%-9K
52.15%-89K
64.06%-115K
111.63%5K
Capital expenditure reported
-57.87%-371K
----
----
55.65%-51K
-736.36%-184K
63.22%-235K
90.00%-9K
52.15%-89K
64.06%-115K
48.84%-22K
Net PPE purchase and sale
--0
18.55%262K
-18.55%-262K
--0
--0
--27K
--221K
---221K
--0
--27K
Cash from discontinued investing activities
Investing cash flow
-78.37%-371K
-1,111.11%-109K
69.66%-27K
55.65%-51K
-3,780.00%-184K
67.45%-208K
90.00%-9K
52.15%-89K
64.06%-115K
111.63%5K
Financing cash flow
Cash flow from continuing financing activities
48.24%-12.34M
74.56%-1.97M
66.63%-1.64M
37.58%-4.49M
-6.40%-4.24M
-472.34%-23.84M
-623.34%-7.75M
-375.17%-4.92M
-611.88%-7.19M
-279.69%-3.98M
Net common stock issuance
58.16%-8.36M
85.18%-994K
83.11%-653K
45.54%-3.49M
-7.73%-3.22M
---19.97M
---6.71M
---3.87M
---6.4M
---2.99M
Cash dividends paid
6.50%-3.98M
5.88%-977K
6.08%-988K
7.40%-1M
6.61%-1.02M
0.51%-4.26M
3.08%-1.04M
1.77%-1.05M
-1.03%-1.08M
-1.78%-1.09M
Proceeds from stock option exercised by employees
--0
--0
--0
--0
--0
233.33%390K
--0
--0
390.00%294K
357.14%96K
Cash from discontinued financing activities
Financing cash flow
48.24%-12.34M
74.56%-1.97M
66.63%-1.64M
37.58%-4.49M
-6.40%-4.24M
-472.34%-23.84M
-623.34%-7.75M
-375.17%-4.92M
-611.88%-7.19M
-279.69%-3.98M
Net cash flow
Beginning cash position
-10.65%82.98M
-4.73%84.27M
-7.89%82.18M
-11.17%83.33M
-10.65%82.98M
23.74%92.87M
0.28%88.45M
5.44%89.22M
15.94%93.81M
23.74%92.87M
Current changes in cash
121.52%1.98M
128.99%1.4M
292.01%2.21M
63.33%-1.67M
-96.76%42K
-152.73%-9.22M
-215.54%-4.82M
-129.51%-1.15M
-226.79%-4.54M
-77.71%1.3M
Effect of exchange rate changes
217.73%797K
114.00%92K
-131.77%-122K
1,230.43%520K
185.75%307K
-299.71%-677K
-234.63%-657K
223.87%384K
-137.10%-46K
-1,067.57%-358K
End cash Position
3.35%85.76M
3.35%85.76M
-4.73%84.27M
-7.89%82.18M
-11.17%83.33M
-10.65%82.98M
-10.65%82.98M
0.28%88.45M
5.44%89.22M
15.94%93.81M
Free cash flow
-1.88%14.32M
15.03%3.37M
2.23%3.85M
6.61%2.82M
-18.54%4.28M
-32.56%14.6M
-44.14%2.93M
-23.67%3.77M
-42.37%2.65M
-23.54%5.25M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -0.94%14.69M18.39%3.48M0.57%3.88M4.02%2.87M-15.39%4.46M-33.44%14.83M-44.92%2.94M-24.70%3.86M-43.78%2.76M-23.70%5.28M
Net income from continuing operations -18.65%11.29M-11.58%2.57M-26.16%2.63M-11.73%3.05M-23.13%3.04M-16.60%13.87M-32.29%2.9M-9.45%3.56M-17.79%3.45M-6.12%3.96M
Depreciation and amortization 5.69%3.01M4.11%760K3.92%769K9.38%758K5.56%721K-55.31%2.85M-29.81%730K-58.54%740K-61.05%693K-61.28%683K
Deferred tax -94.97%-659K-130.51%-18K-430.19%-281K6.21%-151K-14.21%-209K50.37%-338K114.43%59K63.19%-53K-26.77%-161K-18,200.00%-183K
Change In working capital 117.58%317K110.39%86K158.84%263K31.87%-870K11.88%838K-673.82%-1.8M-340.00%-828K11.13%-447K-32.74%-1.28M-15.56%749K
-Change in receivables 142.64%333K190.53%430K-5,522.22%-506K578.31%397K105.61%12K-134.41%-781K-446.72%-475K-110.11%-9K-132.55%-83K-111.96%-214K
-Change in inventory 103.58%1.2M135.44%186K50.75%101K272.35%633K1.48%275K187.61%587K-69.02%79K-79.06%67K205.59%170K125.00%271K
-Change in prepaid assets -68.75%-54K-23.26%-106K-1,133.33%-93K29.55%171K70.11%-26K-171.11%-32K-430.77%-86K-43.75%9K700.00%132K-448.00%-87K
-Change in payables and accrued expense 26.63%-1.16M-22.54%-424K248.05%761K-38.44%-2.07M-25.93%577K16.03%-1.58M-373.97%-346K44.61%-514K-44.68%-1.5M396.18%779K
Cash from discontinued investing activities
Operating cash flow -0.94%14.69M18.39%3.48M0.57%3.88M4.02%2.87M-15.39%4.46M-33.44%14.83M-44.92%2.94M-24.70%3.86M-43.78%2.76M-23.70%5.28M
Investing cash flow
Cash flow from continuing investing activities -78.37%-371K-1,111.11%-109K69.66%-27K55.65%-51K-3,780.00%-184K67.45%-208K90.00%-9K52.15%-89K64.06%-115K111.63%5K
Capital expenditure reported -57.87%-371K--------55.65%-51K-736.36%-184K63.22%-235K90.00%-9K52.15%-89K64.06%-115K48.84%-22K
Net PPE purchase and sale --018.55%262K-18.55%-262K--0--0--27K--221K---221K--0--27K
Cash from discontinued investing activities
Investing cash flow -78.37%-371K-1,111.11%-109K69.66%-27K55.65%-51K-3,780.00%-184K67.45%-208K90.00%-9K52.15%-89K64.06%-115K111.63%5K
Financing cash flow
Cash flow from continuing financing activities 48.24%-12.34M74.56%-1.97M66.63%-1.64M37.58%-4.49M-6.40%-4.24M-472.34%-23.84M-623.34%-7.75M-375.17%-4.92M-611.88%-7.19M-279.69%-3.98M
Net common stock issuance 58.16%-8.36M85.18%-994K83.11%-653K45.54%-3.49M-7.73%-3.22M---19.97M---6.71M---3.87M---6.4M---2.99M
Cash dividends paid 6.50%-3.98M5.88%-977K6.08%-988K7.40%-1M6.61%-1.02M0.51%-4.26M3.08%-1.04M1.77%-1.05M-1.03%-1.08M-1.78%-1.09M
Proceeds from stock option exercised by employees --0--0--0--0--0233.33%390K--0--0390.00%294K357.14%96K
Cash from discontinued financing activities
Financing cash flow 48.24%-12.34M74.56%-1.97M66.63%-1.64M37.58%-4.49M-6.40%-4.24M-472.34%-23.84M-623.34%-7.75M-375.17%-4.92M-611.88%-7.19M-279.69%-3.98M
Net cash flow
Beginning cash position -10.65%82.98M-4.73%84.27M-7.89%82.18M-11.17%83.33M-10.65%82.98M23.74%92.87M0.28%88.45M5.44%89.22M15.94%93.81M23.74%92.87M
Current changes in cash 121.52%1.98M128.99%1.4M292.01%2.21M63.33%-1.67M-96.76%42K-152.73%-9.22M-215.54%-4.82M-129.51%-1.15M-226.79%-4.54M-77.71%1.3M
Effect of exchange rate changes 217.73%797K114.00%92K-131.77%-122K1,230.43%520K185.75%307K-299.71%-677K-234.63%-657K223.87%384K-137.10%-46K-1,067.57%-358K
End cash Position 3.35%85.76M3.35%85.76M-4.73%84.27M-7.89%82.18M-11.17%83.33M-10.65%82.98M-10.65%82.98M0.28%88.45M5.44%89.22M15.94%93.81M
Free cash flow -1.88%14.32M15.03%3.37M2.23%3.85M6.61%2.82M-18.54%4.28M-32.56%14.6M-44.14%2.93M-23.67%3.77M-42.37%2.65M-23.54%5.25M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +10.02%
Sample Name
Sample Code
 +5.43%
Sample Name
Sample Code
 +2.46%
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+1.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+0.70%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.34%
Sample Name
Sample Code
 +11.49%
Sample Name
Sample Code
 +10.29%
4
Futu Holdings Ltd
FUTU
+10.23%
5
Hesai
HSAI
+9.84%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -